Designer Drug
Term · Environment · MLC-T-ENV-007757
Drugs designed and synthesized, often for illegal street use, by modification of existing drug structures (e.g., amphetamines). Of special interest are MPTP (a reverse ester of meperidine), MDA (3,4-methylenedioxyamphetamine), and MDMA (3,4-methylenedioxymethamphetamine). Many drugs act on the aminergic system, the physiologically active biogenic amines.
| Identifier | MLC-T-ENV-007757 |
|---|---|
| Field | Environment |
| References | NLM Medical Subject Headings (MeSH) |
Record as JSON
{
"id": "MLC-T-ENV-007757",
"term": "Designer Drug",
"field": "Environment",
"definition": "Drugs designed and synthesized, often for illegal street use, by modification of existing drug structures (e.g., amphetamines). Of special interest are MPTP (a reverse ester of meperidine), MDA (3,4-methylenedioxyamphetamine), and MDMA (3,4-methylenedioxymethamphetamine). Many drugs act on the aminergic system, the physiologically active biogenic amines.",
"references": [
"NLM Medical Subject Headings (MeSH)"
],
"url": "https://mlchart.com/terminology/environment/designer-drug/"
}
Record 7,757 of 30,736 in Environment terminology (MLC-0121). Request the full dataset.